A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry
Bareng, Joanne, Jilani, Iman, Gorre, Mercedes, Kantarjian, Hagop, Giles, Francis J., Hannah, Alison, Albitar, MaherVolume:
48
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190701607576
Date:
January, 2007
File:
PDF, 1.14 MB
english, 2007